Early is Good Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer (NCT05982561) | Early is Good Inc. | 2023-07-26 |
Track Early is Good Inc. automatically
Every clearance here is in the API, with alerts when new ones post.